Cysteine mutants and methods for detecting ligand binding to biological molecules

Details for Australian Patent Application No. 2002326537 (hide)

Owner SUNESIS PHARMACEUTICALS, INC.

Inventors Flanagan, W. Michael; McDowell, Robert S.

Agent Griffith Hack

Pub. Number AU-A-2002326537

PCT Number PCT/US02/24921

PCT Pub. Number WO2003/014308

Priority 10/121,216 10.04.02 US; 60/310,725 07.08.01 US; 09/981,547 17.10.01 US; 09/990,421 21.11.01 US

Filing date 5 August 2002

Wipo publication date 24 February 2003

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 10/121,216 10.04.02 US; 60/310,725 07.08.01 US; 09/981,547 17.10.01 US; 09/990,421 21.11.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002326537

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326538-VEHICLE ACTIVE NETWORK WITH RESERVED PORTIONS

2002326536-MULTIFUNCTIONAL TOOL AND METHOD FOR MINIMALLY INVASIVE SURGERY